Xcovery
FL - MiamiBiotechnology
Focus: Xcovery is a Miami-based oncology-focused biotechnology company specializing in targeted cancer therapeutics with a commercial-stage product (Ensacove/ensartinib) and an active pipeline across lung cancer, solid tumors, and other malignancies. The company operates as a mid-cap biotech with a diversified pipeline spanning Phase 1 through Phase 3 programs.
Profile data last refreshed 12h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Xcovery
AI assessmentNot HiringNo open roles listed right now. Follow Xcovery to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Xcovery's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Growth10.7yr
Lead commercial product with 10+ year exclusivity window, providing near-term revenue foundation and longer-term strategic runway.
Help build intelligence for Xcovery
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.